Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000670561 | SCV000795424 | uncertain significance | Tay-Sachs disease | 2017-11-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000670561 | SCV000953792 | uncertain significance | Tay-Sachs disease | 2022-10-17 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 45 of the HEXA protein (p.Gln45Pro). This variant is present in population databases (rs144089645, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with HEXA-related conditions. ClinVar contains an entry for this variant (Variation ID: 554858). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genome- |
RCV000670561 | SCV001712336 | uncertain significance | Tay-Sachs disease | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000670561 | SCV003810786 | uncertain significance | Tay-Sachs disease | 2021-11-15 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000670561 | SCV001461912 | uncertain significance | Tay-Sachs disease | 2018-05-22 | no assertion criteria provided | clinical testing |